A synthetic peptide called CJC-1295 acts as an analogue of growth hormone-releasing hormone (GHRH). Because of its capacity to promote the release of growth hormone (GH) and insulin growth factor 1 (IGF-1), it is frequently utilized in research and performance enhancement. A synthetic GHRH analogue with a more focused effect on GH release is tesamorelin, which the FDA licenses to help HIV patients with lipodystrophy lose extra visceral fat.
CJC-1295 attaches itself to pituitary hormone receptors that release growth hormone. Compared to the shorter-acting form without DAC, the version with DAC has a much longer half-life, enabling a longer GH release. In contrast to direct injections of Human Growth Hormone (HGH) it does not provide external hormones; instead, it promotes your body’s natural production of GH and the manufacturer of the product – aasraw utilizes this to the best to give the natural product. It is frequently utilized in the bodybuilding and research sectors, and for a more potent effect, it is occasionally combined with the Ipamorelin (a GH secretagogue).
Potential Benefits
It has been studied for potential therapeutic uses, but it is also used in bodybuilding and anti-aging medicine. It is primarily available as a research chemical. It assists for an increased muscle growth and fat loss. It enhances recovery and healing. To describe its benefits more, it helps improve skin health and sleep quality. It aids in strengthening the immune system. Tesamorelin peptide has approved for HIV-related lipodystrophy and for fat Loss, often used for stubborn belly fat reduction. It greatly supports for cognitive Health and may help in memory and brain function in older adults.
Dosage and Administration
While the non-DAC variant is sometimes given more frequently (e.g., daily or every other day), the standard practice involves injecting CJC-1295 (with DAC) at a dose of 2 mg each week, without DAC it can be given 100-300 mcg per day, often stacked with Ipamorelin for better results. Tesamorelin peptide can be given 2 mg per day (subcutaneous injection, typically in the abdominal area) and often taken before bed for best GH release. Because there aren’t many long-term human trials, it should be utilized cautiously even though it’s frequently employed in peptide treatment. The best time to inject is morning or before bed (for optimal growth hormone release) and subcutaneous injection (under the skin) is the most common method. Know more about the peptide and select trustworthy peptide suppliers that provide high-purity, lab-tested products when buying. The cycle length can be maintained for 3-6 months for better results.
